info@australianvisionresearch.org

DONATE NOW

Australian Vision Research
  • About
    • About
    • Contact
    • News
  • Grants
  • Excellence Awards
  • Research
  • AVR Insights
  • Members
  • AVR Bequest Program
  • Donate
A novel calpain antagonist for ischemic retinal vein occlusion

A novel calpain antagonist for ischemic retinal vein occlusion

by AVR Supporters | Nov 4, 2022 | Research

R and L Lowe Bequest Grant  Investigator: Dr Glyn Chidlow Co-Investigator: Dr Andreas Ebneter Aim: Retinal vein occlusions are common disorders which occur when blood clots block veins within the retina.The aims of this project are to establish translatable rodent...
Optimising a pipeline for developing treatment for CRB1-related inherited retinal diseases

Optimising a pipeline for developing treatment for CRB1-related inherited retinal diseases

by AVR Supporters | Oct 9, 2022 | Research

This grant was funded by the Australian and New Zealand Society of Retinal Specialists (ANZRS) Investigator: A/Prof Fred K. ChenCo-investigator: Prof Sue Fletcher Aim: In this project the aimed was to:1) generate personalised retinal cell models for patients with CRB1...
A new drug to control scarring after glaucoma surgery

A new drug to control scarring after glaucoma surgery

by AVR Supporters | Sep 6, 2022 | News, Research

ORIA Grant Progress Report 2019-2020 Title: A new drug to control scarring after glaucoma surgery Investigator: Dr Elsa Chan Co-investigators: Dr Manisha Shah, Dr Jennifer Fan Gaskin Aim:Toevaluate the anti-scarring properties of 3ʼ,4ʼ-dihydroxyflavonol (DiOHF) in...
Applying machine learning to efficiently analyse fundus autofluorescence images in preparation for gene therapy 

Applying machine learning to efficiently analyse fundus autofluorescence images in preparation for gene therapy 

by AVR Supporters | Aug 8, 2022 | Research

A Perth Eye Foundation grant recipient Chief investigator: Dr Jason Charng Co-investigators: Dr David Alonso-Caneiro, Prof David Mackey Eyes with retinitis pigmentosa (RP) show a characteristic hyperautofluorescent ring (HAR) with fundus autofluorescence (FAF)...
Near-infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema

Near-infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema

by AVR Supporters | Jul 8, 2022 | Research

Last year, Dr Elisa Cornish (Chief Investigator) and A/Prof Samantha Fraser-Bell (Other Investigator) received a Priming Grant to the value of $50,000 for their work titled “Near-infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema” In...
Harnessing the power of AI for eye disease screening in primary care

Harnessing the power of AI for eye disease screening in primary care

by AVR Supporters | Feb 1, 2021 | Research

Dr Stuart Keel, Centre for Eye Research Australia, University of Melbourne, Victoria Up to 500,000 adults in Australia have vision impairment or blindness but it is estimated that 80% of vision loss is avoidable through early detection, prevention and treatment...
« Older Entries
Next Entries »

Recent Posts

  • Perth Eye Foundation Grant: RNA base editing for treatment of inherited retinal diseases
  • Identifying cardiovascular disease parameters with high clinical relevance in primary open-angle glaucoma
  • Grants Round 2025 Open
  • Amyloid and Tau targeting to protect Retinal Ganglion Cell and Optic Nerve in glaucoma
  • Targeting Nrf2-MAFF pathway in Müller cells to treat macular degeneration

Recent Comments

No comments to show.
Australian Vision Research

© Copyright 2024 Australian Vision Research ABN 37008393146

About
Grants
Research
News
Members
Contact

CONTACT US

PO BOX 3109
Erina NSW 2250
 

For all enquiries contact us on

info@australianvisionresearch.org

Privacy Policy

  • Follow
  • Follow
  • Follow
  • Follow

Australian Vision Research conforms to the highest corporate governance standards with its fully audited annual financial statements and reports publicly available.